K-877 (pemafibrate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for K-877 (pemafibrate), covering 2025-05-23 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C [Phase 3]